Dr. Arnon Chait is an entrepreneur, scientist and educator who brings vast experience commercializing innovative science to his role as CEO of Cleveland Diagnostics. Arnon co-founded Cleveland Diagnostics with the Cleveland Clinic to bring early detection of cancer into everyday practice with advanced testing that is both simple and affordable. With a background in physics, engineering and biosciences, a career spanning NASA, academia and private industry, and a history of launching and leading groundbreaking ventures with sustained revenues, Arnon has a proven track record bringing innovation to market. He has co-invented numerous patents, has published extensively, and has developed technologies of significant impact in life sciences, from opto-electronics to novel non-invasive prenatal diagnostics—and now, novel but simple blood-based testing to make a lasting impact to benefit patients, providers, and the healthcare system.
"Our ‘A PSA on PSA’ campaign is a public service initiative designed to drive those important patient-provider conversations and get more patients screened for prostate cancer." - Medical Marketing Media (MM+M)
“This is important work,” Chait said. “Better diagnostics translates into better outcomes for patients and resource preservation for an overwhelmed healthcare system. Today, we mostly treat late-stage cancers – an expensive approach for our healthcare system and a demanding endeavor for patients and their families. Shifting to prioritize the early detection of cancer using simple blood tests is vital – this recent financing news validates its importance." - Crain's Cleveland Business
"You see new smartphones coming out constantly, and it’s human nature to want the next shiny new toy. This concept also applies to science. For example, the next microscope may have better resolution, but we must ask ourselves: will it allow me to do the job better? Is it really necessary to answer a clinically relevant question?" - The Pathologist